Overview
Project Summary
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, emphasizing the urgent need for the development of new therapies with higher efficacy. Thus, this project aims to generate bispecific theranostic nanosystems, with the ability to target both HCC cells and cancer stem cells, and to co-deliver anticancer and sonophotosensitizer drugs, promoting a strong antitumor activity and reduced side effects.
Coordination
Project Details
Project Code
CENTRO2030-FEDER-02364100
Region
Transnacional
Start Date
2026-02-01
End Date
2027-07-30
Funding Details
CENTRO2030-FEDER-02364100
